Skip to main content
. Author manuscript; available in PMC: 2012 May 17.
Published in final edited form as: Hepatology. 2008 Feb;47(2):563–570. doi: 10.1002/hep.22048

Table 2.

SNP Data and Analysis

A. Counts and Frequencies of Individual SNP Genotypes*
All PBC (n = 351) Control (n = 205) AMA+ PBC (n = 303) AMA− PBC (n = 44) OLT PBC (n = 29) Non-OLT PBC (n = 322)
CTLA4 49AG
 AA 131 (0.37) 79 (0.39) 112 (0.37) 19 (0.43) 8 (0.28) 123 (0.38)
 AG 161 (0.46) 99 (0.48) 134 (0.44) 24 (0.55) 12 (0.41) 149 (0.46)
 GG 59 (0.17) 27 (0.13) 57 (0.19) 1 (0.02) 9 (0.31) 50 (0.16)
CTLA4 CT60
 GG 117 (0.33) 70 (0.34) 105 (0.35) 10 (0.23) 15 (0.52) 102 (0.32)
 AG 168 (0.48) 94 (0.46) 142 (0.47) 24 (0.55) 13 (0.45) 155 (0.48)
 AA 66 (0.19) 41 (0.20) 56 (0.18) 10 (0.23) 1 (0.03) 65 (0.20)
PDCD1 PD1.3
 GG 267 (0.76) 161 (0.79) 236 (0.78) 29 (0.66) 22 (0.76) 245 (0.76)
 AG 80 (0.23) 40 (0.20) 64 (0.21) 15 (0.34) 5 (0.17) 75 (0.23)
 AA 4 (0.01) 4 (0.02) 3 (0.01) 0 2 (0.07) 2 (0.01)
B. Statistical Analysis of SNP Genotypes Based on Logistic Regression and Adjusted for Age and Sex
All PBC Versus Controls
AMA+ Versus AMA− PBC
OLT Versus Non-OLT PBC
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
CTLA4 49AG
 Log-additive 1.11 (0.86–1.42) 0.44 1.67 (1.03–2.71) 0.04 1.69 (1.00–2.88) 0.05
 Dominant 1.05 (0.73–1.51) 0.79 1.35 (0.71–2.58) 0.36 1.71 (0.73–4.00) 0.22
 Recessive (GG) 1.33 (0.81–2.20) 0.26 9.96 (1.34–73.97) 0.02 2.46 (1.05–5.76) 0.04
CTLA4 CT60
 Log-additive 1.00 (0.78–1.27) 0.97 0.71 (0.45–1.12) 0.14 0.44 (0.24–0.81) 0.008
 Dominant 1.05 (0.72–1.52) 0.80 0.55 (0.26–1.17) 0.12 0.43 (0.20–0.93) 0.03
 Recessive (AA) 0.92 (0.59–1.43) 0.71 0.73 (0.34–1.58) 0.43 0.13 (0.02–0.99) 0.05
PDCD1 PD1.3
 Log-additive 1.05 (0.72–1.55) 0.78 0.62 (0.33–1.17) 0.14 1.35 (0.62–2.93) 0.46
 Dominant 1.12 (0.74–1.71) 0.59 0.54 (0.27–1.08) 0.08 1.01 (0.41–2.47) 0.99
 Recessive (AA) 0.55 (0.13–2.36) 0.43 14.74 (1.89–114.9) 0.01
*

Values are expressed as count (frequency).

Bold text indicates statistically significant findings (i.e., P ≤ 0.05).